/Lists

Biotech Investors & VC Firms in Asia-Pacific

746 firms in this list, with a median first check of $500K. 161 of them lead rounds. Generated from verified public data and updated continuously.

Droia Ventures
LuxembourgSeed–Series B$540K
40 people
SR One Capital Management
Redwood CitySeed–Series B
31 people
Capricorn Venture Partners
LeuvenSeed–Growth$270K – $10.8M
30 people
Wavemaker Three-Sixty Health
Los AngelesSeed–Series A$500K – $2M
28 people
TCG Labs
South San Francisco
49 people
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
36 people
Blue Revolution Investments G.P.
BergenSeed–Series A
31 people
Nina Capital
BarcelonaPre-Seed–Seed$215K – $1.6M
24 people
SeaX Ventures
MillbraePre-Seed–Series A$100K – $5M
35 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
Decheng Capital
Menlo ParkSeed–Growth
14 people
VantagePoint Capital Partners
Silicon ValleySeed–Growth$2M – $100M
18 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
DOMiNO Ventures
AmsterdamPre-Seed–Seed$216K – $1.1M
31 people
Karista
ParisPre-Seed–Growth$324K – $5.4M
12 people
SAV (Scale Asia Ventures)
Palo AltoSeed–Series B
16 people
DRI Healthcare
Toronto
40 people
OMERS Private Equity Inc.
TorontoGrowth
26 people
HCVC
ParisPre-Seed–Series A$100K – $1M
7 people
Intrepid Growth Partners
TorontoGrowth
28 people
Impact Fund Denmark
CopenhagenSeed–Late Stage$2.2M – $70.2M
36 people
Version One Ventures
VancouverPre-Seed–Seed$250K – $500K
4 people
SVG Ventures | THRIVE
Santa ClaraPre-Seed–Series A$10K – $100K
27 people
Vibe Capital
San FranciscoPre-Seed–Series A$250K – $500K
3 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.